Sprint Bioscience: Collaborates to expand its MASH inflammation programme - Redeye

Sprint Bioscience has entered a research collaboration with the Experimental Drug Development Centre (EDDC) in Singapore regarding the therapeutic expansion of Sprint Bioscience’s MASH (metabolic dysfunction-associated steatohepatitis) programme based on STK25 into inflammatory diseases.

Länk till analysen i sin helhet: https://www.redeye.se/research/1116051/sprint-bioscience-collaborates-to-expand-its-mash-inflammation-programme?utm_source=finwire&utm_medium=RSS